Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Anesthesiology. 2018 Dec;129(6):1171–1184. doi: 10.1097/ALN.0000000000002399

Table 1.

Composition of available prothrombin complex concentrates

Product
(Manufacturer)
Coagulation factor content (IU) Antithrombotic content (IU)

II VII IX X Protein C Protein S ATIII
Beriplex P/N
(CSL Behring)
400–960 200–500 400–620 440–1200 300–900 240–760 4–30

Octaplex
(Octapharma)
280–760 180–480 500 360–600 260–620 240–640 0

Prothromplex Total
(Shire/Baxalta)
480–900 500 600 600 400 Not declared Not declared

Cofact/PPSB
SD/Kanokad
(Sanquin/CAF)
280–700 140–400 500 280–700 222–780 20–160 ≤0.6

Uman Complex
(Kedrion)
500 Not declared 500 400 Not declared Not declared 2.5

Profilnine
(Grifols)
150 35 100 100 Not declared Not declared Not declared

Bebulin
(Shire/Baxalta)
Not
declared
Not declared (low) Not declared Not declared Not declared Not declared Not declared

FEIBA
(Shire/Baxalta)
Present*
mainly
non-
activated
Present*
activated
Present*
mainly
non-
activated
Present,*
mainly
non-
activated
Not
declared
Not declared Not declared

ATIII, antithrombin III. Data are based on the prescribing information of each product, as of January 2017.

*

Indicates that values are not provided in the prescribing information, just the presence or absence of the coagulation factor